Form 4: Vor Biopharma Executive Eyal C. Attar Reports Stock Transaction
SEC Form 4 Filing
Eyal C. Attar, Chief Medical Officer of Vor Biopharma Inc., reports disposition of shares to cover tax obligations related to restricted stock units.
Summary
- On August 6, 2024, Eyal C. Attar, the Chief Medical Officer of Vor Biopharma Inc., disposed of 999 shares of common stock.
- The shares were withheld to satisfy tax obligations related to the settlement of restricted stock units.
- The transaction price was $0.87 per share.
- Following the transaction, Attar directly owns 93,918 shares of Vor Biopharma Inc.
Sentiment
Score: 5
Explanation: Neutral sentiment as the filing relates to a routine transaction for tax purposes and doesn't indicate a change in the executive's confidence in the company.
Industry Context
This is a routine filing related to executive compensation and tax obligations. It doesn't necessarily reflect a change in the executive's outlook on the company.
Key Dates
| Date | Description |
|---|---|
| 08/06/2024 | Date of stock transaction (disposal of shares). |
| 08/08/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.